Fermenta Biotech Limited (NSE:FERMENTA)

Market Cap	9.22B +17.6%
Revenue (ttm)	5.48B +16.7%
Net Income	717.65M -6.6%
EPS	24.51 -7.0%
Shares Out	n/a
PE Ratio	12.85
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	39,028
Open	303.30
Previous Close	301.10
Day's Range	302.75 - 318.00
52-Week Range	248.85 - 330.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	May 26, 2026

About Fermenta Biotech

Fermenta Biotech Limited, together with its subsidiaries, manufactures and markets chemicals, bulk drugs, and enzymes in India, Europe, the United States, and internationally. It provides pharmaceutical formulations and environmental solutions; rents and sells properties; and sports and health awareness/education services. The company also offers various variants of vitamin D3, including crystalline oil, resin oil, cold water dispersible, and feed grade powder for use in various applications, such as pharmaceuticals, dietary and nutritional sup...

• Industry: Pharmaceutical Preparations
• Founded: 1951
• Employees: 606
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: FERMENTA

Financial Performance

In fiscal year 2026, Fermenta Biotech's revenue was 5.48 billion, an increase of 16.69% compared to the previous year's 4.69 billion. Earnings were 717.65 million, a decrease of -6.63%.